These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 18095639)

  • 21. High expression of hTERT and stemness genes in BORIS/CTCFL positive cells isolated from embryonic cancer cells.
    Alberti L; Renaud S; Losi L; Leyvraz S; Benhattar J
    PLoS One; 2014; 9(10):e109921. PubMed ID: 25279549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The structural complexity of the human BORIS gene in gametogenesis and cancer.
    Pugacheva EM; Suzuki T; Pack SD; Kosaka-Suzuki N; Yoon J; Vostrov AA; Barsov E; Strunnikov AV; Morse HC; Loukinov D; Lobanenkov V
    PLoS One; 2010 Nov; 5(11):e13872. PubMed ID: 21079786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BORIS/CTCFL-mediated transcriptional regulation of the hTERT telomerase gene in testicular and ovarian tumor cells.
    Renaud S; Loukinov D; Alberti L; Vostrov A; Kwon YW; Bosman FT; Lobanenkov V; Benhattar J
    Nucleic Acids Res; 2011 Feb; 39(3):862-73. PubMed ID: 20876690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PRAME expression and promoter hypomethylation in epithelial ovarian cancer.
    Zhang W; Barger CJ; Eng KH; Klinkebiel D; Link PA; Omilian A; Bshara W; Odunsi K; Karpf AR
    Oncotarget; 2016 Jul; 7(29):45352-45369. PubMed ID: 27322684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-dependent activation of putative oncogene SBSN by BORIS.
    Gaykalova D; Vatapalli R; Glazer CA; Bhan S; Shao C; Sidransky D; Ha PK; Califano JA
    PLoS One; 2012; 7(7):e40389. PubMed ID: 22792300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA methylation and nucleosome occupancy regulate the cancer germline antigen gene MAGEA11.
    James SR; Cedeno CD; Sharma A; Zhang W; Mohler JL; Odunsi K; Wilson EM; Karpf AR
    Epigenetics; 2013 Aug; 8(8):849-63. PubMed ID: 23839233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
    Alberti L; Losi L; Leyvraz S; Benhattar J
    PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The testis-specific factor CTCFL cooperates with the protein methyltransferase PRMT7 in H19 imprinting control region methylation.
    Jelinic P; Stehle JC; Shaw P
    PLoS Biol; 2006 Oct; 4(11):e355. PubMed ID: 17048991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic activation of POTE genes in ovarian cancer.
    Sharma A; Albahrani M; Zhang W; Kufel CN; James SR; Odunsi K; Klinkebiel D; Karpf AR
    Epigenetics; 2019 Feb; 14(2):185-197. PubMed ID: 30764732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BORIS binding to the promoters of cancer testis antigens, MAGEA2, MAGEA3, and MAGEA4, is associated with their transcriptional activation in lung cancer.
    Bhan S; Negi SS; Shao C; Glazer CA; Chuang A; Gaykalova DA; Sun W; Sidransky D; Ha PK; Califano JA
    Clin Cancer Res; 2011 Jul; 17(13):4267-76. PubMed ID: 21558405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide investigation of regional blood-based DNA methylation adjusted for complete blood counts implicates BNC2 in ovarian cancer.
    Winham SJ; Armasu SM; Cicek MS; Larson MC; Cunningham JM; Kalli KR; Fridley BL; Goode EL
    Genet Epidemiol; 2014 Jul; 38(5):457-66. PubMed ID: 24853948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BORIS (CTCFL) is not expressed in most human breast cell lines and high grade breast carcinomas.
    Hines WC; Bazarov AV; Mukhopadhyay R; Yaswen P
    PLoS One; 2010 Mar; 5(3):e9738. PubMed ID: 20305816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BAT3 and SET1A form a complex with CTCFL/BORIS to modulate H3K4 histone dimethylation and gene expression.
    Nguyen P; Bar-Sela G; Sun L; Bisht KS; Cui H; Kohn E; Feinberg AP; Gius D
    Mol Cell Biol; 2008 Nov; 28(21):6720-9. PubMed ID: 18765639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the epigenetic factor BORIS (CTCFL) in the human genome.
    de Necochea-Campion R; Ghochikyan A; Josephs SF; Zacharias S; Woods E; Karimi-Busheri F; Alexandrescu DT; Chen CS; Agadjanyan MG; Carrier E
    J Transl Med; 2011 Dec; 9():213. PubMed ID: 22168535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evolution of epigenetic regulators CTCF and BORIS/CTCFL in amniotes.
    Hore TA; Deakin JE; Marshall Graves JA
    PLoS Genet; 2008 Aug; 4(8):e1000169. PubMed ID: 18769711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
    Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
    Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cancer-associated CTCFL/BORIS protein targets multiple classes of genomic repeats, with a distinct binding and functional preference for humanoid-specific SVA transposable elements.
    Pugacheva EM; Teplyakov E; Wu Q; Li J; Chen C; Meng C; Liu J; Robinson S; Loukinov D; Boukaba A; Hutchins AP; Lobanenkov V; Strunnikov A
    Epigenetics Chromatin; 2016; 9(1):35. PubMed ID: 27588042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The novel BORIS + CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer.
    Klenova EM; Morse HC; Ohlsson R; Lobanenkov VV
    Semin Cancer Biol; 2002 Oct; 12(5):399-414. PubMed ID: 12191639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intertumor and intratumor NY-ESO-1 expression heterogeneity is associated with promoter-specific and global DNA methylation status in ovarian cancer.
    Woloszynska-Read A; Mhawech-Fauceglia P; Yu J; Odunsi K; Karpf AR
    Clin Cancer Res; 2008 Jun; 14(11):3283-90. PubMed ID: 18519754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single CpG island methylation is not sufficient to maintain the silenced expression of CASPASE-8 apoptosis-related gene among women with epithelial ovarian cancer.
    Braga Lda C; Silva LM; Ramos AP; Piedade JB; Vidigal PV; Traiman P; da Silva Filho AL
    Biomed Pharmacother; 2014 Feb; 68(1):87-91. PubMed ID: 24412083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.